Financials
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 49 M323 M233 M90 M5 M-142 M 186 M Non-Operating Income, Total 102 M-133 M140 M95 M23 M33 M 291 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 98 M-136 M138 M87 M18 M26 M 269 M Unusual income/expense 4 M3 M2 M8 M5 M7 M 22 M Pretax income 53 M326 M373 M5 M18 M81 M 477 M Equity in earnings 48 M-1 M16 M31 M66 M14 M 127 M Taxes 30 M-22 M45 M41 M43 M-51 M 78 M Non-controlling/minority interest 43 M—230 M43 M27 M— — After tax other income/expense -1 M5 M1 M8 M12 M11 M 32 M Net income before discontinued operations 40 M-149 M98 M79 M34 M-187 M 24 M Discontinued operations 00——3 M1 M — Net income 40 M-149 M98 M79 M37 M-186 M 28 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 40 M-149 M98 M79 M37 M-186 M 28 M Basic earnings per share (Basic EPS) -0.43-1.23-1.050.84-0.40.31 -0.3 Diluted earnings per share (Diluted EPS) 0.43-1.59-1.050.84-0.4-1.98 -2.59 Average basic shares outstanding 93.5 M93.5 M93.7 M94 M94 M93.9 M 375.6 M Diluted shares outstanding 93.5 M93.5 M93.7 M94 M94 M93.9 M 375.6 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 200 M220 M156 M182 M203 M228 M 769 M